STOCK TITAN

Guardant Health to Participate in Upcoming June Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Guardant Health, Inc. (Nasdaq: GH), a leader in precision oncology, will participate in two upcoming investor conferences. The first is the William Blair 42nd Annual Growth Stock Conference in Chicago on June 7 at 11:20 a.m. CT. The second is the Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes on June 14 at 9:20 a.m. PT. Live and archived webcasts will be available on the company's website. Guardant Health focuses on advanced cancer tests to improve patient outcomes and reduce healthcare costs.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.

  • William Blair 42nd Annual Growth Stock Conference in Chicago, IL
    Presentation on Tuesday, June 7th at 11:20 a.m. Central Time
  • Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA
    Fireside Chat on Tuesday, June 14 th at 9:20 a.m. Pacific Time

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.

Investor Contact:

Alex Kleban

investors@guardanthealth.com

+1 657-254-5417

Media Contact:

Michele Rest

press@guardanthealth.com

+1 215-910-2138

Source: Guardant Health, Inc.

FAQ

When will Guardant Health participate in the William Blair Growth Stock Conference?

Guardant Health will present at the William Blair 42nd Annual Growth Stock Conference on June 7 at 11:20 a.m. Central Time.

What is the date for Guardant Health's appearance at the Goldman Sachs Healthcare Conference?

Guardant Health is scheduled for a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14 at 9:20 a.m. Pacific Time.

Where can I watch the webcasts of Guardant Health's investor conference presentations?

Live and archived webcasts of Guardant Health's presentations will be available on the Investors section of their website.

What does Guardant Health do?

Guardant Health is a precision oncology company focused on improving cancer care through advanced testing and analytics.

Guardant Health, Inc.

NASDAQ:GH

GH Rankings

GH Latest News

GH Stock Data

4.02B
117.89M
4.56%
104.62%
8.33%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
PALO ALTO